Crohn’s Disease and Obesity Clinical Trials

Over the past few decades, obesity has become increasingly common among people living with Crohn’s disease. For example, one U.S. study found that the percentage of hospitalized Crohn’s disease patients with obesity rose from 1.8% in 2002 to 9.5% in 2017. Today, it’s estimated that 15–40% of adults with Crohn’s disease are obese, while another 20–40% are overweight. These rising numbers highlight a growing concern, as excess weight can worsen inflammation, complicate treatment, and increase the risk of complications.

To address this growing challenge, researchers are now conducting Crohn’s disease and obesity clinical trials to explore new ways to manage both conditions together. These studies aim to find potential treatment for Crohn’s disease and obesity by focusing on improved inflammation control, weight management strategies, and better long-term outcomes. By participating in ongoing research, patients can contribute to future treatment options while accessing advanced care that may help improve their overall health.